Patent details

Basic Information

Publication number:

EP1033978

PCT Application Number:

PCT/EP/99/01795

Type:

European Patent Granted for LU

Legal Status:

Expired

Application number:

EP999103591

PCT Publication Number:

WO/99/49852

First applicant's nationality:

Translation Language:

EPO Publication Language:

German

English Title of Invention:

TRANSDERMAL THERAPEUTIC SYSTEM WHICH CONTAINS A D2 AGONIST AND WHICH IS PROVIDED FOR TREATING PARKINSONISM, AND A METHOD FOR THE PRODUCTION THEREOF

French Title of Invention:

SYSTEME THERAPEUTIQUE TRANSDERMIQUE CONTENANT UN AGONISTE D2 SERVANT A TRAITER LE SYNDROME PARKINSONIEN, ET SON PROCEDE DE PRODUCTION

German Title of Invention:

D2-AGONIST ENTHALTENDES TRANSDERMALES THERAPEUTISCHES SYSTEM ZUR BEHANDLUNG DES PARKINSON-SYNDROMS UND VERFAHREN ZU SEINER HERSTELLUNG

SPC Number:

91269

Dates

Filing date:

18/03/1999

Grant date:

19/12/2001

EP Publication Date:

19/12/2001

PCT Publication Date:

07/10/1999

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

13/09/2000

EP B1 Publication Date:

19/12/2001

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

18/03/2019

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

12/07/2017

 

 

Name:

LTS Lohmann Therapie-Systeme AG

Address:

Lohmannstrasse 2, 56626 Andernach, Germany (DE)

Name:

UCB Biopharma SPRL

Address:

60, Allée de la Recherche, 1070 Brussels, Belgium (BE)

History of Owners

From:

28/03/2012

To:

12/07/2017

Name:

UCB MANUFACTURING IRELAND LIMITED

Address:

SHANNON INDUSTRIAL ESTATE, SHANNON COUNTY CLARE, Ireland (IE)

From:

26/07/2006

To:

27/03/2012

Name:

SCHWARZ PHARMA LIMITED

Address:

SHANNON INDUSTRIAL ESTATE, SHANNON, COUNTY CLARE, Ireland (IE)

From:

18/03/1999

To:

25/07/2006

Name:

DISCOVERY THERAPEUTICS INC.

Address:

2028 DABNEY ROAD - SUITE E 17, RICHMOND, VIRGINIA 23230-3311, United States (US)

From:

18/03/1999

To:

12/07/2017

Name:

LTS Lohmann Therapie-Systeme AG

Address:

Lohmannstrasse 2, 56626 Andernach, Germany (DE)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

23/01/2002

Address:

PO Box 48, 8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

MÜLLER Walter

Address:

Germany (DE)

2

Name:

PECK James, V.

Address:

United States (US)

Priority

Priority Number:

19814084

Priority Date:

30/03/1998

Priority Country:

Germany (DE)

Classification

Main IPC Class:

A61K 9/70;

Publication

Bulletin

Bulletin Heading:

CO

Bulletin edition number:

2017/04

Publication date:

04/08/2017

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of ownership

Deed Number:

RC20170000244A

Date Registered:

12/07/2017

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

1

Name:

UCB Biopharma SPRL

Address:

60, Allée de la Recherche, 1070 Brussels, Belgium (BE)

2

Name:

LTS Lohmann Therapie-Systeme AG

Address:

Lohmannstrasse 2, 56626 Andernach, Germany (DE)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

21/03/2018

Last Annual Fee Paid Number:

20

Last Annual Fee Paid Amount:

300 Euro

Payer:

DENNEMEYER & CO

Filing date	Document type	Number of pages
12/07/2017	Request For Change	4